These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3328103)

  • 1. [Comparison of 3 high-permeability dialysers].
    Montagnac R; Schillinger F; Milcent T; Cheriot J; Dupoirieux J; Turret MM; Manceaux JC
    Nephrologie; 1987; 8(5):257-9. PubMed ID: 3328103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the beta 2-microglobulin level during hemodialysis].
    Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
    Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
    Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
    Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in beta 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers.
    Mineshima M; Hoshino T; Era K; Kitano Y; Suzuki T; Sanaka T; Teraoka S; Agishi T; Ota K
    ASAIO Trans; 1990; 36(3):M643-6. PubMed ID: 2252773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will nephrologists use a wearable artificial kidney?
    Friedman EA
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1401-2. PubMed ID: 19661217
    [No Abstract]   [Full Text] [Related]  

  • 11. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form.
    Niwa T; Aiuchi T; Nakaya K; Emoto Y; Miyazaki T; Maeda K
    Clin Nephrol; 1993 Feb; 39(2):92-6. PubMed ID: 8448924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASAHI hollow fiber kidney (ASAHI HFK) --- progress report.
    Maeda K; Ota K; Saito A; Shimoji T; Amano I
    Trans Am Soc Artif Intern Organs; 1974; 20A():344-52. PubMed ID: 4450356
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
    Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
    Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative evaluation of low-flow rate hemodialysis with sequential use of 2 membranes of differing permeability].
    Canaud B; Polito C; Laroche B; Dupont M; Mion C
    Nephrologie; 1986; 7(3):119-22. PubMed ID: 3774084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.